{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:15:17Z","timestamp":1790712917088,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79542-5","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T01:57:15Z","timestamp":1731635835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sandwich immunoassay for adrenomedullin precursor and its practical application"],"prefix":"10.1038","volume":"14","author":[{"given":"Paul","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Ilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"79542_CR1","doi-asserted-by":"publisher","unstructured":"Fischer, J. P., Els-Heindl, S. & Beck-Sickinger, A. G. Adrenomedullin \u2013 current perspective on a peptide hormone with significant therapeutic potential. Peptides (N Y). 131, 170347. https:\/\/doi.org\/10.1016\/J.PEPTIDES.2020.170347 (2020).","DOI":"10.1016\/J.PEPTIDES.2020.170347"},{"issue":"5","key":"79542_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/cvd.2012.012003","volume":"1","author":"HK Wong","year":"2012","unstructured":"Wong, H. K., Cheung, T. T. & Cheung, B. M. Y. Adrenomedullin and cardiovascular diseases. JRSM Cardiovasc. Dis. 1(5), 1\u20137. https:\/\/doi.org\/10.1258\/cvd.2012.012003 (2012).","journal-title":"JRSM Cardiovasc. Dis."},{"issue":"2","key":"79542_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1073\/pnas.98.2.615","volume":"98","author":"KM Caron","year":"2001","unstructured":"Caron, K. M. & Smithies, O. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc. Natl. Acad. Sci. U S A. 98(2), 615\u2013619. https:\/\/doi.org\/10.1073\/pnas.98.2.615 (2001).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"79542_CR4","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1128\/mcb.26.7.2511-2518.2006","volume":"26","author":"RT Dackor","year":"2006","unstructured":"Dackor, R. T. et al. Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor Gene. Mol. Cell. Biol. 26(7), 2511\u20132518. https:\/\/doi.org\/10.1128\/mcb.26.7.2511-2518.2006 (2006).","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"79542_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12031-015-0696-1","volume":"59","author":"S Fukuda","year":"2016","unstructured":"Fukuda, S. et al. Glucagon-like peptide-1 strengthens the barrier integrity in primary cultures of rat brain endothelial cells under basal and hyperglycemia conditions. J. Mol. Neurosci. 59 (2), 211\u2013219. https:\/\/doi.org\/10.1007\/s12031-015-0696-1 (2016).","journal-title":"J. Mol. Neurosci."},{"key":"79542_CR6","doi-asserted-by":"publisher","unstructured":"Koyama, T. et al. Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis. Circulation. 127(7), 842\u2013853. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000756 (2013).","DOI":"10.1161\/CIRCULATIONAHA.112.000756"},{"key":"79542_CR7","doi-asserted-by":"publisher","unstructured":"Hayakawa, H. et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension. 33(2), 689\u2013693. https:\/\/doi.org\/10.1161\/01.HYP.33.2.689 (1999).","DOI":"10.1161\/01.HYP.33.2.689"},{"issue":"2","key":"79542_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1165\/rcmb.2009-0004OC","volume":"43","author":"A Vadivel","year":"2010","unstructured":"Vadivel, A. et al. Adrenomedullin promotes lung angiogenesis, alveolar development, and repair. Am. J. Respir. Cell. Mol. Biol. 43(2), 152\u2013160. https:\/\/doi.org\/10.1165\/rcmb.2009-0004OC (2010).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"issue":"6","key":"79542_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.33549\/physiolres.931032","volume":"56","author":"B Haditsch","year":"2007","unstructured":"Haditsch, B., Roessler, A. & Hinghofer-Szalkay, H. G. Renal adrenomedullin and high altitude diuresis. Physiol. Res. 56(6), 779\u2013787 (2007).","journal-title":"Physiol. Res."},{"issue":"3","key":"79542_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000320562","volume":"26","author":"D Bell","year":"2010","unstructured":"Bell, D. et al. Adrenomedullin gene delivery is cardio-protective in a model of chronic nitric oxide deficiency combining pressure overload, oxidative stress and cardiomyocyte hypertrophy. Cell. Physiol. Biochem. 26 (3), 383\u2013394. https:\/\/doi.org\/10.1159\/000320562 (2010).","journal-title":"Cell. Physiol. Biochem."},{"key":"79542_CR11","doi-asserted-by":"publisher","unstructured":"Elena, T. et al. Anti-inflammatory effects of adrenomedullin on acute lung injury induced by carrageenan in mice. Mediators Inflamm. 2012. https:\/\/doi.org\/10.1155\/2012\/717851 (2012).","DOI":"10.1155\/2012\/717851"},{"issue":"4","key":"79542_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/CDLI.10.4.546-551.2003","volume":"10","author":"RP Allaker","year":"2003","unstructured":"Allaker, R. P. & Kapas, S. Adrenomedullin expression by gastric epithelial cells in response to infection. Clin. Diagn. Lab. Immunol. 10(4), 546\u2013551. https:\/\/doi.org\/10.1128\/CDLI.10.4.546-551.2003 (2003).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"79542_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/psc.2953","volume":"23","author":"R Sch\u00f6nauer","year":"2017","unstructured":"Sch\u00f6nauer, R., Els-Heindl, S. & Beck-Sickinger, A. G. Adrenomedullin: New perspectives of a potent peptide hormone. J. Pept. Sci. 23, 7\u20138. https:\/\/doi.org\/10.1002\/psc.2953 (2017).","journal-title":"J. Pept. Sci."},{"issue":"10","key":"79542_CR14","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1373\/clinchem.2005.051110","volume":"51","author":"NG Morgenthaler","year":"2005","unstructured":"Morgenthaler, N. G., Struck, J., Alonso, C. & Bergmann, A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin. Chem. 51(10), 1823\u20131829. https:\/\/doi.org\/10.1373\/clinchem.2005.051110 (2005).","journal-title":"Clin. Chem."},{"key":"79542_CR15","doi-asserted-by":"publisher","unstructured":"Neumann, J. T. et al. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease. Atherosclerosis. 228(2), 451\u2013459. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2013.03.006 (2013).","DOI":"10.1016\/J.ATHEROSCLEROSIS.2013.03.006"},{"issue":"5","key":"79542_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/eurjhf\/hfq031","volume":"12","author":"S Von Haehling","year":"2010","unstructured":"Von Haehling, S. et al. Mid-regional pro\u2010adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur. J. Heart Fail. 12(5), 484\u2013491 (2010).","journal-title":"Eur. J. Heart Fail."},{"key":"79542_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14225","author":"E Valeriani","year":"2024","unstructured":"Valeriani, E. et al. Midregional-Proadrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis. Eur. J. Clin. Invest. https:\/\/doi.org\/10.1111\/eci.14225 (2024).","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"79542_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1566-3","volume":"16","author":"D Liu","year":"2016","unstructured":"Liu, D., Xie, L., Zhao, H., Liu, X. & Cao, J. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: A systematic review and meta-analysis. BMC Infect. Dis. 16(1), 1\u201311. https:\/\/doi.org\/10.1186\/s12879-016-1566-3 (2016).","journal-title":"BMC Infect. Dis."},{"key":"79542_CR19","doi-asserted-by":"publisher","unstructured":"Fialek, B. et al. Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients. Ann. Med. 55(1), 379\u2013387. https:\/\/doi.org\/10.1080\/07853890.2022.2162116 (2023).","DOI":"10.1080\/07853890.2022.2162116"},{"key":"79542_CR20","doi-asserted-by":"publisher","unstructured":"Buerger, K. et al. Prediction of Alzheimer\u2019s disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: A retrospective analysis of 134 patients with mild cognitive impairment. 1\u20138. https:\/\/doi.org\/10.4088\/JCP.09m05872oli (2010).","DOI":"10.4088\/JCP.09m05872oli"},{"key":"79542_CR21","doi-asserted-by":"publisher","unstructured":"Krintus, M. et al. Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population. Clin. Chem Lab Med 56(7), 1161\u20131168 . https:\/\/doi.org\/10.1515\/cclm-2017-1044 (2018).","DOI":"10.1515\/cclm-2017-1044"},{"key":"79542_CR22","doi-asserted-by":"publisher","unstructured":"Prigge, S. T., Mains, R. E., Eipper, B. A. & Amzel, L. M. New insights into copper monooxygenases and peptide amidation: Structure, mechanism and function. Cell. Mol. Life Sci. 57(8\u20139), 1236\u20131259. https:\/\/doi.org\/10.1007\/PL00000763 (2000).","DOI":"10.1007\/PL00000763"},{"issue":"4","key":"79542_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2217\/ije-2017-0015","volume":"4","author":"JF Rehfeld","year":"2017","unstructured":"Rehfeld, J. F. The long goodbye to glycine-extended peptide hormones. Int. J. Endocr. Oncol. 4(4), 147\u2013149. https:\/\/doi.org\/10.2217\/ije-2017-0015 (2017).","journal-title":"Int. J. Endocr. Oncol."},{"key":"79542_CR24","doi-asserted-by":"publisher","unstructured":"Nomura, I., Kato, J., Tokashiki, M. & Kitamura, K. Increased plasma levels of the mature and intermediate forms of adrenomedullin in obesity. Regul. Pept. 158(1\u20133), 127\u2013131. https:\/\/doi.org\/10.1016\/J.REGPEP.2009.08.003 (2009).","DOI":"10.1016\/J.REGPEP.2009.08.003"},{"key":"79542_CR25","doi-asserted-by":"crossref","unstructured":"Hirayama, N. et al. Molecular forms of circulating adrenomedullin in patients with congestive heart failure. [Online].  http:\/\/www.endocrinology.org (1999).","DOI":"10.1677\/joe.0.1600297"},{"key":"79542_CR26","doi-asserted-by":"publisher","unstructured":"Nishikimi, T. et al. Different secretion patterns of two molecular forms of cardiac adrenomedullin in pressure- and volume-overloaded human heart failure. J. Card Fail. 10(4), 321\u2013327. https:\/\/doi.org\/10.1016\/j.cardfail.2003.12.002 (2004).","DOI":"10.1016\/j.cardfail.2003.12.002"},{"issue":"4","key":"79542_CR27","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/00004872-200104000-00014","volume":"19","author":"T Nishikimi","year":"2001","unstructured":"Nishikimi, T. et al. Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure. J. Hypertens. 19(4), 765\u2013773. https:\/\/doi.org\/10.1097\/00004872-200104000-00014 (2001).","journal-title":"J. Hypertens."},{"key":"79542_CR28","doi-asserted-by":"publisher","unstructured":"Ohta, H. et al. A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin. Chim. Acta. 287, 1\u20132. https:\/\/doi.org\/10.1016\/S0009-8981(99)00128-X (1999).","DOI":"10.1016\/S0009-8981(99)00128-X"},{"key":"79542_CR29","doi-asserted-by":"publisher","unstructured":"Yoshikawa, D. et al. Increased plasma concentrations of the mature form of adrenomedullin during cardiac surgery and hepatosplanchnic hypoperfusion. Anesth Analg.,97(3), 663\u2013670 (2003). https:\/\/doi.org\/10.1213\/01.ANE.0000072543.78106.AA","DOI":"10.1213\/01.ANE.0000072543.78106.AA"},{"key":"79542_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1291\/hypres.26.S45","volume":"26","author":"J Yamaga","year":"2003","unstructured":"Yamaga, J. et al. Direct measurement of glycine-extended adrenomedullin in plasma and tissue using an ultrasensitive immune complex transfer enzyme immunoassay in rats. Hypertens. Res. 26, 45\u201353. https:\/\/doi.org\/10.1291\/hypres.26.S45 (2003).","journal-title":"Hypertens. Res."},{"issue":"2","key":"79542_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1006\/bbrc.1998.8310","volume":"244","author":"K Kitamura","year":"1998","unstructured":"Kitamura, K. et al. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem. Biophys. Res. Commun. 244(2), 551\u2013555. https:\/\/doi.org\/10.1006\/bbrc.1998.8310 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"79542_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1053\/euhj.1999.1904","volume":"21","author":"F Pousset","year":"2000","unstructured":"Pousset, F. et al. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur. Heart J. 21(12), 1009\u20131014. https:\/\/doi.org\/10.1053\/euhj.1999.1904 (2000).","journal-title":"Eur. Heart J."},{"key":"79542_CR33","doi-asserted-by":"publisher","unstructured":"Nishikimi, T. & Nakagawa, Y. Adrenomedullin as a biomarker of heart failure. Heart Fail. Clin. 14(1), 49\u201355. https:\/\/doi.org\/10.1016\/j.hfc.2017.08.006  (2018).","DOI":"10.1016\/j.hfc.2017.08.006"},{"issue":"10","key":"79542_CR34","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1172\/JCI118680","volume":"97","author":"M Jougasaki","year":"1996","unstructured":"Jougasaki, M. et al. Cardiac secretion of adrenomedullin in human heart failure. J. Clin. Invest. 97(10), 2370\u20132376. https:\/\/doi.org\/10.1172\/JCI118680 (1996).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"79542_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/CS19980070","volume":"96","author":"M Kakishita","year":"1999","unstructured":"Kakishita, M. et al. Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin. Sci. 96(1), 33\u201339. https:\/\/doi.org\/10.1042\/CS19980070 (1999).","journal-title":"Clin. Sci."},{"key":"79542_CR36","doi-asserted-by":"publisher","unstructured":"Fran\u00e7ois, B. et al. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: The prospective observational multinational adrenomedullin and outcome in sepsis and septic shock-1 (AdrenOSS-1) study. Crit. Care. 22(1), 1\u201312. https:\/\/doi.org\/10.1186\/s13054-018-2243-2 (2018).","DOI":"10.1186\/s13054-018-2243-2"},{"key":"79542_CR37","doi-asserted-by":"publisher","unstructured":"Lundberg, O. H. M. et al. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness. Crit. Care. 1\u201310. https:\/\/doi.org\/10.1186\/s13054-020-03351-1 (2020).","DOI":"10.1186\/s13054-020-03351-1"},{"key":"79542_CR38","doi-asserted-by":"publisher","unstructured":"Chen, Y. X. & Li, C. S. The predictive value of adrenomedullin for development of severe sepsis and septic shock in emergency department. Biomed. Res. Int. 2013(December 2011). https:\/\/doi.org\/10.1155\/2013\/960101 (2013).","DOI":"10.1155\/2013\/960101"},{"key":"79542_CR39","doi-asserted-by":"publisher","unstructured":"Nagaya, N. et al. Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart. 84(6), 653\u2013658. https:\/\/doi.org\/10.1136\/heart.84.6.653 (2000).","DOI":"10.1136\/heart.84.6.653"},{"issue":"2","key":"79542_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13543784.2021.1857365","volume":"30","author":"B Deniau","year":"2021","unstructured":"Deniau, B., Takagi, K., Asakage, A. & Mebazaa, A. Adrecizumab: an investigational agent for the biomarker-guided treatment of sepsis. Expert Opin. Investig. Drugs. 30(2), 95\u2013102 (2021).","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"9","key":"79542_CR41","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/bcp.13655","volume":"84","author":"C Geven","year":"2018","unstructured":"Geven, C. et al. Safety, tolerability and pharmacokinetics\/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects. Br. J. Clin. Pharmacol. 84(9), 2129\u20132141. https:\/\/doi.org\/10.1111\/bcp.13655 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"79542_CR42","doi-asserted-by":"publisher","unstructured":"Nagata, S., Yamasaki, M. & Kitamura, K. Anti-inflammatory effects of PEGylated human adrenomedullin in a mouse DSS-induced colitis model. Drug Dev. Res. 78(3\u20134), 129\u2013134. https:\/\/doi.org\/10.1002\/ddr.21383 (2017).","DOI":"10.1002\/ddr.21383"},{"key":"79542_CR43","doi-asserted-by":"publisher","unstructured":"Nagata, S., Yamasaki, M., & Kitamura, K. Polyethylene glycol-conjugated human adrenomedullin as a possible treatment for vascular dementia. Peptides (N.Y.) 121(170133). https:\/\/doi.org\/10.1016\/j.peptides.2019.170133 (2019).","DOI":"10.1016\/j.peptides.2019.170133"},{"issue":"1","key":"79542_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1210\/jc.82.1.95","volume":"82","author":"K Meeran","year":"1997","unstructured":"Meeran, K. et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: A pharmacokinetic study. J. Clin. Endocrinol. Metab. 82(1), 95\u2013100. https:\/\/doi.org\/10.1210\/jc.82.1.95 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"79542_CR45","doi-asserted-by":"publisher","first-page":"15791","DOI":"10.1038\/s41598-021-95305-y","volume":"11","author":"P Kaufmann","year":"2021","unstructured":"Kaufmann, P., Bergmann, A. & Melander, O. Novel insights into peptide amidation and amidating activity in the human circulation. Sci. Rep. 11(1), 15791 (2021).","journal-title":"Sci. Rep."},{"key":"79542_CR46","doi-asserted-by":"publisher","unstructured":"Weber, J. et al. Sandwich immunoassay for bioactive plasma adrenomedullin. J. Appl. Lab. Med. AACC Publ. 2(2), 222\u2013233. https:\/\/doi.org\/10.1373\/jalm.2017.023655 (2017).","DOI":"10.1373\/jalm.2017.023655"},{"key":"79542_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.peptides.2014.05.005","volume":"57","author":"K Kubo","year":"2014","unstructured":"Kubo, K., Tokashiki, M., Kuwasako, K., Tamura, M. & Tsuda, S. Peptides biological properties of adrenomedullin conjugated with polyethylene glycol. Peptides (N Y). 57, 118\u2013121. https:\/\/doi.org\/10.1016\/j.peptides.2014.05.005 (2014).","journal-title":"Peptides (N Y)"},{"key":"79542_CR48","unstructured":"Armbruster, D. A. & Pry, T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem. Rev. 29(Suppl 1), S49\u2013S52 [Online]. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18852857%0A (2008)."},{"key":"79542_CR49","doi-asserted-by":"crossref","unstructured":"Ohta, H. et al. One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. Clin. Chem. 45(2), 244\u2013251 (1999).","DOI":"10.1093\/clinchem\/45.2.244"},{"key":"79542_CR50","doi-asserted-by":"publisher","unstructured":"Spoto, S. et al. A focus on the pathophysiology of adrenomedullin expression: Endothelitis and organ damage in severe viral and bacterial infections. Cells. 13(11). https:\/\/doi.org\/10.3390\/cells13110892 (2024).","DOI":"10.3390\/cells13110892"},{"key":"79542_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10030524","volume":"10","author":"K Czajkowska","year":"2021","unstructured":"Czajkowska, K. et al. Mid-regional proadrenomedullin as a new biomarker of kidney and cardiovascular diseases\u2014Is it the future? J. Clin. Med. 10, 1\u201314. https:\/\/doi.org\/10.3390\/jcm10030524 (2021).","journal-title":"J. Clin. Med."},{"issue":"2","key":"79542_CR52","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3233\/JAD-220195","volume":"88","author":"N Kuriyama","year":"2022","unstructured":"Kuriyama, N. et al. Association between cerebral microbleeds and circulating levels of mid-regional pro-adrenomedullin. J. Alzheimer\u2019s Dis.. 88(2), 731\u2013741. https:\/\/doi.org\/10.3233\/JAD-220195 (2022).","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"4","key":"79542_CR53","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3233\/JAD-160901","volume":"56","author":"N Kuriyama","year":"2017","unstructured":"Kuriyama, N. et al. Association between mid-regional proadrenomedullin levels and progression of deep white matter lesions in the brain accompanying cognitive decline. J. Alzheimer\u2019s Dis. 56(4), 1253\u20131262. https:\/\/doi.org\/10.3233\/JAD-160901 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"2","key":"79542_CR54","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/ndt\/gfm600","volume":"23","author":"S Oba","year":"2008","unstructured":"Oba, S., Hino, M. & Fujita, T. Adrenomedullin protects against oxidative stress-induced podocyte injury as an endogenous antioxidant. Nephrol. Dial. Transplant. 23(2), 510\u2013517. https:\/\/doi.org\/10.1093\/ndt\/gfm600 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"79542_CR55","doi-asserted-by":"publisher","unstructured":"Hippenstiel, S. et al. Adrenomedullin reduces endothelial hyperpermeability. Circ. Res. 91(7), 618\u2013625. https:\/\/doi.org\/10.1161\/01.RES.0000036603.61868.F9 (2002).","DOI":"10.1161\/01.RES.0000036603.61868.F9"},{"key":"79542_CR56","doi-asserted-by":"publisher","unstructured":"Mitome-Mishima, Y. et al. Adrenomedullin deficiency and aging exacerbate ischemic white matter injury after prolonged cerebral hypoperfusion in mice. Biomed. Res. Int. 2014 https:\/\/doi.org\/10.1155\/2014\/861632 (2014).","DOI":"10.1155\/2014\/861632"},{"key":"79542_CR57","doi-asserted-by":"crossref","unstructured":"Shindo, T., Kurihara, H. & Maemura, K. Hypotension and resistance to Lipopolysaccharide-Induced shock in transgenic mice overexpressing adrenomedullin in their vasculature, 2309\u20132316 (2000).","DOI":"10.1161\/01.CIR.101.19.2309"},{"issue":"4","key":"79542_CR58","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00134-007-0561-y","volume":"33","author":"B Temmesfeld-Wollbr\u00fcck","year":"2007","unstructured":"Temmesfeld-Wollbr\u00fcck, B. et al. Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock. Intensive Care Med. 33(4), 703\u2013710. https:\/\/doi.org\/10.1007\/s00134-007-0561-y (2007).","journal-title":"Intensive Care Med."},{"issue":"34","key":"79542_CR59","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1073\/pnas.0803174105","volume":"105","author":"AP Fern\u00e1ndez","year":"2008","unstructured":"Fern\u00e1ndez, A. P., Serrano, J., Tessarollo, L., Cuttitta, F. & Mart\u00ednez, A. Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions. Proc. Natl. Acad. Sci. U S A. 105(34), 12581\u201312586. https:\/\/doi.org\/10.1073\/pnas.0803174105 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"79542_CR60","unstructured":"Zhou, M. et al. The small intestine is an important source of adrenomedullin release during polymicrobial sepsis the small intestine is an important source of adrenomedullin release during polymicrobial sepsis (2011)."},{"issue":"2","key":"79542_CR61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0022-1759(85)90207-8","volume":"81","author":"RD Lane","year":"1985","unstructured":"Lane, R. D. A short-duration polyethylene glycol fusion technique for increasing production of monoclonal antibody-secreting hybridomas. J. Immunol. Methods. 81(2), 223\u2013228. https:\/\/doi.org\/10.1016\/0022-1759(85)90207-8 (1985).","journal-title":"J. Immunol. Methods"},{"key":"79542_CR62","doi-asserted-by":"publisher","unstructured":"Hikawa, N. & Takenaka, T. Method for production of neuronal hybridoma using emetine and actinomycin D. Brain Res. Protoc. 1(3), 224\u2013226. https:\/\/doi.org\/10.1016\/S1385-299X(96)00031-1 (1997).","DOI":"10.1016\/S1385-299X(96)00031-1"},{"key":"79542_CR63","doi-asserted-by":"publisher","unstructured":"Struck, J., Hein, F., Karasch, S. & Bergmann, A. Epitope specificity of anti-adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model. Intensive Care Med. Exp.. 1(1). https:\/\/doi.org\/10.1186\/2197-425X-1-3 (2013).","DOI":"10.1186\/2197-425X-1-3"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79542-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T02:04:31Z","timestamp":1731636271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79542-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79542"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79542-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.K., Y.I. and M.P. are employed by PAM Theragnostics GmbH, A.B. has shares in and is managing director of PAM Theragnostics GmbH, the commercial manufacturer of the ADM-Gly assay.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28091"}}